1. Home
  2. PSNL vs CPAC Comparison

PSNL vs CPAC Comparison

Compare PSNL & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • CPAC
  • Stock Information
  • Founded
  • PSNL 2011
  • CPAC 1949
  • Country
  • PSNL United States
  • CPAC Peru
  • Employees
  • PSNL N/A
  • CPAC N/A
  • Industry
  • PSNL Medical Specialities
  • CPAC Building Materials
  • Sector
  • PSNL Health Care
  • CPAC Industrials
  • Exchange
  • PSNL Nasdaq
  • CPAC Nasdaq
  • Market Cap
  • PSNL 484.0M
  • CPAC 580.5M
  • IPO Year
  • PSNL 2019
  • CPAC 2012
  • Fundamental
  • Price
  • PSNL $5.24
  • CPAC $6.78
  • Analyst Decision
  • PSNL Strong Buy
  • CPAC Hold
  • Analyst Count
  • PSNL 4
  • CPAC 1
  • Target Price
  • PSNL $8.13
  • CPAC $6.40
  • AVG Volume (30 Days)
  • PSNL 900.5K
  • CPAC 4.8K
  • Earning Date
  • PSNL 11-05-2025
  • CPAC 10-27-2025
  • Dividend Yield
  • PSNL N/A
  • CPAC 7.39%
  • EPS Growth
  • PSNL N/A
  • CPAC 26.68
  • EPS
  • PSNL N/A
  • CPAC 0.14
  • Revenue
  • PSNL $80,317,000.00
  • CPAC $572,828,408.00
  • Revenue This Year
  • PSNL N/A
  • CPAC N/A
  • Revenue Next Year
  • PSNL $29.83
  • CPAC N/A
  • P/E Ratio
  • PSNL N/A
  • CPAC $9.57
  • Revenue Growth
  • PSNL 0.36
  • CPAC 3.37
  • 52 Week Low
  • PSNL $2.83
  • CPAC $5.10
  • 52 Week High
  • PSNL $7.79
  • CPAC $6.90
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 54.55
  • CPAC 66.58
  • Support Level
  • PSNL $4.73
  • CPAC $6.67
  • Resistance Level
  • PSNL $4.97
  • CPAC $6.82
  • Average True Range (ATR)
  • PSNL 0.26
  • CPAC 0.17
  • MACD
  • PSNL 0.10
  • CPAC 0.04
  • Stochastic Oscillator
  • PSNL 96.39
  • CPAC 85.54

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

Share on Social Networks: